CRISPR-based Biosensors for Human Health: A Novel Strategy to Detect Emerging Infectious Diseases

Yawen He1, Qinqin Hu2,3, Samantha San1

  • 1Department of Biological Systems Engineering, Virginia Tech, Blacksburg, VA 24061, USA.

Insights

Clustered regularly interspaced short palindromic repeats (CRISPR) technology offers a sensitive and specific method for detecting infectious diseases. This review explores CRISPR-based biosensors for rapid pathogen identification and discusses future directions for human health applications.

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Infectious Disease Diagnostics

Background:

  • Infectious diseases pose a global health threat, necessitating rapid detection methods.
  • Current diagnostic techniques face limitations in speed, sensitivity, or specificity.
  • Clustered regularly interspaced short palindromic repeats (CRISPR) technology presents a promising next-generation molecular diagnostic tool.

Purpose of the Study:

  • To review the latest advancements in CRISPR-based biosensors for infectious disease detection.
  • To explore the potential of CRISPR technology in human health applications.
  • To address the critical need for summarizing CRISPR biosensor development in infectious disease diagnostics.

Main Methods:

  • Overview of current CRISPR-based biosensor strategies for pathogen detection.
  • Analysis of pre-amplification methods used in CRISPR diagnostics.
  • Examination of different CRISPR systems and their unique features.
  • Discussion of biosensing designs for detecting disease-associated nucleic acids.

Main Results:

  • CRISPR technology demonstrates high flexibility, sensitivity, and specificity for pathogen detection.
  • Various CRISPR-based biosensors have been developed for diverse applications.
  • This review consolidates current knowledge on CRISPR biosensors for infectious diseases.

Conclusions:

  • CRISPR-based biosensors hold significant potential for rapid and accurate infectious disease diagnosis.
  • Further research and development are needed to overcome current challenges.
  • CRISPR technology is poised to revolutionize infectious disease detection and management in human health.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
24
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
31